Magic Ink for Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the safety and effectiveness of Magic Ink, a special tattoo ink, for women with breast cancer undergoing radiation therapy. The researchers aim to determine if Magic Ink is as safe as regular tattoo ink and remains visible for radiation therapists during treatment. Women diagnosed with certain stages of breast cancer and planning to start radiation after surgery might be suitable candidates. Participants will receive Magic Ink tattoos and undergo skin assessments and surveys to track their experiences. As an unphased trial, this study provides a unique opportunity for patients to contribute to innovative research that could enhance radiation therapy experiences.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that Magic Ink is safe for use in radiation therapy for breast cancer patients?
Research has shown that Magic Ink tattoos have undergone thorough testing and are considered safe and effective. This ink is unique because it appears only under ultraviolet light, distinguishing it from regular tattoo inks. So far, studies have not identified any major safety issues with Magic Ink. Although general concerns exist about tattoos being linked to a higher risk of certain cancers, this has not been specifically associated with Magic Ink.
The trial compares Magic Ink to regular tattoo ink to ensure it is equally safe. Previous studies have generally found regular tattoo inks to be well-tolerated, though individual reactions can vary. Participants in the trial will have their skin checked for irritation or other issues. Current evidence suggests Magic Ink is safe, but this trial will help confirm that.12345Why are researchers excited about this trial?
Researchers are excited about the Magic Ink treatment because it offers a novel way to improve precision in breast cancer radiation therapy. Unlike traditional methods that rely on visible ink or skin markers, Magic Ink uses a tattoo ink that is only visible under ultraviolet light. This means it can provide guidance for radiation without permanent visible marks, potentially reducing discomfort and improving the patient experience. By enhancing accuracy in targeting cancer cells while minimizing impact on healthy tissue, Magic Ink could lead to more effective and less invasive treatment options.
What evidence suggests that Magic Ink is effective for breast cancer radiation treatment?
Research has shown that Magic Ink, visible only under ultraviolet light, can enhance the quality of life for cancer patients undergoing radiation therapy. Studies have found that patients with these UV ink tattoos were very satisfied with their appearance and felt free to wear any clothing they desired, unlike some who used regular tattoo ink. Additionally, Magic Ink may simplify the setup process for radiation therapists. Overall, early evidence suggests that Magic Ink may be as safe and effective as regular tattoo ink for marking treatment areas.16789
Who Is on the Research Team?
Michael Dominello, DO
Principal Investigator
Wayne State University
Are You a Good Fit for This Trial?
This trial is for women over 18 with stage 0, I, II or III breast cancer who are planning radiation therapy post-surgery. They must understand and sign consent, have a good performance status (able to carry out normal activities), and not be at risk of pregnancy either through surgery, menopause, same-sex relationships or agree to use contraception.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Radiation
Participants receive Magic Ink tattoos and undergo radiation treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Magic Ink
Find a Clinic Near You
Who Is Running the Clinical Trial?
Barbara Ann Karmanos Cancer Institute
Lead Sponsor